Compare GDRX & LMRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDRX | LMRI |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 702.3M | 753.7M |
| IPO Year | 2020 | N/A |
| Metric | GDRX | LMRI |
|---|---|---|
| Price | $2.31 | $9.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | $3.66 | ★ $20.75 |
| AVG Volume (30 Days) | ★ 1.3M | 1.0M |
| Earning Date | 05-06-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.00 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $796,853,000.00 | N/A |
| Revenue This Year | N/A | $6.35 |
| Revenue Next Year | $5.38 | $5.61 |
| P/E Ratio | $25.56 | ★ N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $1.77 | $7.23 |
| 52 Week High | $5.61 | $19.45 |
| Indicator | GDRX | LMRI |
|---|---|---|
| Relative Strength Index (RSI) | 55.57 | 44.43 |
| Support Level | $2.11 | $7.23 |
| Resistance Level | $2.47 | $10.35 |
| Average True Range (ATR) | 0.10 | 0.63 |
| MACD | 0.02 | 0.20 |
| Stochastic Oscillator | 68.92 | 53.44 |
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists' interpretations of those studies.